 CHARLOTTESVILLE, Va. and CARMEL, Ind., March 16, 2022 GLOBE NEWSWIRE -- Acumen Pharmaceuticals, Inc. NASDAQ: ABOS, a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimers disease AD, today announced that the company will report its financial results for the fourth quarter and full year 2021 on Monday, March 28, 2022. The company will host a conference call and live audio webcast at 4:30 p.m. ET to provide a business and financial update. 